Hedge funds brace for regulation
Article Abstract:
The hedge fund industry is lobbying against a controversial regulation by outgoing Chairman William Donaldson of the United States Securities and Exchange Commission, that would require most hedge fund managers to register with the Commission by 2006. The regulation change does not have the full support of other United States regulators.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
American Pharmaceutical faces probe over cancer drug
Article Abstract:
American Pharmaceutical Partners is being investigated by the Securities Exchange Commission over allegations that it misled investors about issues involving its Abraxane breast-cancer drug.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Biovail is focus of an inquiry into kickbacks
Article Abstract:
Biovail is being probed in the U.S. for allegedly paying bribes to physicians who prescribe one of the company's heart drugs. Biovail has denied any wrongdoing on its part.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Inventory control under speculation: myopic heuristics and exact procedures. Resource-constrained multi-project scheduling with tardy costs: comparing myopic, bottleneck, and resource pricing heuristics
- Abstracts: Street sleuth: making banks accountable for terror. Palestinian Bank faces U.S. probe on laundering. Bush tightens curbs on Hamas finances
- Abstracts: WPP posts 20% profit increase on global market share gains. (WPP Group PLC). WPP's revenue jumps 26%